GCM
TTPH

Gruss Capital Management’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Gruss Capital Management’s Portfolio TTPH Stock Details TTPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-15,000
Closed -$1.39M – 53
2016
Q1 		$1.39M Hold
15,000
– – 0.04% 44
2015
Q4 		$3.01M Hold
15,000
– – 0.1% 64
2015
Q3 		$2.24M Buy
+15,000
New +$11M 0.07% 68

Other funds holding TTPH

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Gruss Capital Management's TTPH Position: Q2 2016 in Review

Gruss Capital Management sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q2 2016, closing a stake of 15,000 shares — an estimated $1.39M sold.

Gruss Capital Management first reported a position in TTPH in Q3 2015 and held it in 3 quarters. The position peaked at $3.01M in Q4 2015. 91 funds tracked by Wall St. Rank hold TTPH as of Q2 2016.

  • Gruss Capital Management reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q2 2016 after selling out during the quarter.
  • Gruss Capital Management sold 15,000 Tetraphase Pharmaceuticals, Inc. shares in Q2 2016, an estimated $1.39M.
  • Gruss Capital Management first reported a position in Tetraphase Pharmaceuticals, Inc. in Q3 2015 and held it in 3 quarters.
  • Gruss Capital Management's Tetraphase Pharmaceuticals, Inc. position peaked at $3.01M in Q4 2015.
  • 91 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q2 2016.

Based on Gruss Capital Management's 13F filing for Q2 2016, filed 12 Aug 2016.